PUBLISHER: Persistence Market Research | PRODUCT CODE: 1747214
PUBLISHER: Persistence Market Research | PRODUCT CODE: 1747214
CRISPR Gene editing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
Persistence Market Research has recently released a comprehensive report on the worldwide market for CRISPR gene-editing technology. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global CRISPR gene-editing market from 2025 to 2032.
Key Insights:
- CRISPR Gene-Editing Market Size (2025E): USD 5.06 Billion
- Projected Market Value (2032F): USD 11.02 Billion
- Global Market Growth Rate (CAGR 2025 to 2032): 11.80%
CRISPR Gene-Editing Market - Report Scope:
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) gene-editing technology is revolutionizing the field of molecular biology and medicine by enabling precise, efficient, and cost-effective genome modifications. This groundbreaking technology is utilized in a wide range of applications, including genetic research, therapeutic development, agriculture, and diagnostics. The CRISPR gene-editing market serves pharmaceutical companies, biotechnology firms, academic research institutions, and clinical laboratories. Market growth is driven by the increasing demand for advanced gene therapies, expanding research in rare and chronic genetic disorders, and the rising prevalence of inherited diseases.
Market Growth Drivers:
The global CRISPR gene-editing market is propelled by several key factors, including growing investments in genomic research and the rising incidence of genetic disorders requiring targeted treatment solutions. The emergence of CRISPR-based therapeutic candidates, supported by regulatory approvals for clinical trials, significantly boosts market momentum. Moreover, CRISPR technology's potential to address previously untreatable conditions, such as sickle cell anemia and certain forms of cancer, strengthens its appeal among both researchers and investors. The declining cost of genome sequencing and editing further supports widespread adoption across pharmaceutical R&D and personalized medicine.
Market Restraints:
Despite its transformative potential, the CRISPR gene-editing market faces significant regulatory, ethical, and technical challenges. Stringent regulatory frameworks governing the clinical application of gene-editing technologies can delay product development and commercialization. Ethical concerns regarding germline editing and off-target effects also raise public scrutiny and influence policy decisions. Furthermore, high research costs and intellectual property disputes among key patent holders may restrict technology access for smaller players, impeding innovation and market entry.
Market Opportunities:
The CRISPR gene-editing market presents vast opportunities driven by expanding therapeutic pipelines, increasing strategic collaborations, and technological refinements. Applications in agriculture, such as the development of genetically modified crops with enhanced traits, and advancements in CRISPR diagnostics, including CRISPR-based COVID-19 tests, broaden the market scope. Strategic partnerships between biotech startups and pharmaceutical giants enhance innovation and accelerate time-to-market. Continuous improvement in CRISPR delivery systems, such as base editing and prime editing, enhances precision and expands therapeutic potential, paving the way for next-generation genetic interventions.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the CRISPR gene-editing market globally?
- Which CRISPR applications are fueling adoption across the healthcare and agricultural sectors?
- How are technological innovations shaping the future of CRISPR-based therapies and diagnostics?
- Who are the key players in the CRISPR gene-editing space, and what strategies are they adopting to gain a competitive edge?
- What are the emerging trends and future prospects in the global CRISPR gene-editing market?
Competitive Intelligence and Business Strategy:
These companies invest heavily in developing therapeutic candidates for rare and complex diseases, including beta-thalassemia, Leber congenital amaurosis, and various cancers. Collaborations with academic institutions, contract research organizations, and multinational pharmaceutical firms facilitate technology advancement and regulatory navigation. Emphasis on clinical trial success, safety data transparency, and public engagement is essential for long-term market leadership in this ethically sensitive and highly regulated domain.
Key Companies Profiled:
- Revvity, Inc.
- Danaher
- GenScript
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Tocris Bioscience
- OriGene Technologies, Inc.
- Bio-Rad Laboratories
- Bio-Techne
- New England Biolabs, Inc.
CRISPR Gene-Editing Market Research Segmentation:
The CRISPR gene-editing market encompasses a diverse array of applications, technologies, and end-user segments, addressing multiple industries and patient populations.
By Product
- Kits & Enzymes
- Libraries
- Others
By Service
- gRNA Design and Vector Construction
- Cell Line Engineering
- Screening Services
- Other Services
By Application
- Drug Discovery & Development
- Agriculture
- Others
By Region
- North America
- Europe
- Asia Pacific
- South Asia and Oceania
- Latin America
- Middle East and Africa
Table of Contents
1. Executive Summary
- 1.1. CRISPR Gene-Editing Market Snapshot, 2025-2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
- 3.1. Regulatory Landscape
- 3.2. Pipeline Analysis
- 3.3. Product Adoption Analysis
- 3.4. Value Chain Analysis
- 3.5. Key Promotional Strategies by Manufacturers
- 3.6. PESTLE Analysis
- 3.7. Porter's Five Force Analysis
4. CRISPR Gene-Editing Market Outlook:
- 4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
- 4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
- 4.3. Global CRISPR Gene-Editing Market Market Outlook: Product
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2024
- 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 4.3.3.1. Kits & Enzymes
- 4.3.3.2. Libraries
- 4.3.3.3. Others
- 4.3.4. Market Attractiveness Analysis: Product
- 4.4. Global CRISPR Gene-Editing Market Market Outlook: Service
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn) Analysis, Service, 2019-2024
- 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Service, 2025-2032
- 4.4.3.1. gRNA Design and Vector Construction
- 4.4.3.2. Cell Line Engineering
- 4.4.3.3. Screening Services
- 4.4.3.4. Other Services
- 4.4.4. Market Attractiveness Analysis: Service
- 4.5. Global CRISPR Gene-Editing Market Outlook: Application
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
- 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 4.5.3.1. Drug Discovery & Development
- 4.5.3.2. Agriculture
- 4.5.3.3. Others
- 4.5.4. Market Attractiveness Analysis: Application
5. Global CRISPR Gene-Editing Market Outlook: Region
- 5.1. Key Highlights
- 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
- 5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
- 5.4. Market Attractiveness Analysis: Region
6. North America CRISPR Gene-Editing Market Outlook:
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 6.2.1. By Product
- 6.2.2. By Service
- 6.2.3. By Application
- 6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 6.3.1. U.S.
- 6.3.2. Canada
- 6.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 6.4.1. Kits & Enzymes
- 6.4.2. Libraries
- 6.4.3. Others
- 6.5. Market Size (US$ Bn) Analysis and Forecast, By Service, 2025-2032
- 6.5.1. gRNA Design and Vector Construction
- 6.5.2. Cell Line Engineering
- 6.5.3. Screening Services
- 6.5.4. Other Services
- 6.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 6.6.1. Drug Discovery & Development
- 6.6.2. Agriculture
- 6.6.3. Others
- 6.7. Market Attractiveness Analysis
7. Europe CRISPR Gene-Editing Market Market Outlook:
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Type
- 7.2.3. By Service
- 7.2.4. By Application
- 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
- 7.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 7.4.1. Kits & Enzymes
- 7.4.2. Libraries
- 7.4.3. Others
- 7.5. Market Size (US$ Bn) Analysis and Forecast, By Service, 2025-2032
- 7.5.1. gRNA Design and Vector Construction
- 7.5.2. Cell Line Engineering
- 7.5.3. Screening Services
- 7.5.4. Other Services
- 7.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 7.6.1. Drug Discovery & Development
- 7.6.2. Agriculture
- 7.6.3. Others
- 7.7. Market Attractiveness Analysis
8. East Asia CRISPR Gene-Editing Market Outlook:
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Type
- 8.2.3. By Service
- 8.2.4. By Service
- 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 8.4.1. Kits & Enzymes
- 8.4.2. Libraries
- 8.4.3. Others
- 8.5. Market Size (US$ Bn) Analysis and Forecast, By Service, 2025-2032
- 8.5.1. gRNA Design and Vector Construction
- 8.5.2. Cell Line Engineering
- 8.5.3. Screening Services
- 8.5.4. Other Services
- 8.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 8.6.1. Drug Discovery & Development
- 8.6.2. Agriculture
- 8.6.3. Others
- 8.7. Market Attractiveness Analysis
9. South Asia & Oceania CRISPR Gene-Editing Market Outlook:
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Product
- 9.2.3. By Service
- 9.2.4. By Application
- 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
- 9.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 9.4.1. Kits & Enzymes
- 9.4.2. Libraries
- 9.4.3. Others
- 9.5. Market Size (US$ Bn) Analysis and Forecast, By Service, 2025-2032
- 9.5.1. gRNA Design and Vector Construction
- 9.5.2. Cell Line Engineering
- 9.5.3. Screening Services
- 9.5.4. Other Services
- 9.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 9.6.1. Drug Discovery & Development
- 9.6.2. Agriculture
- 9.6.3. Others
- 9.7. Market Attractiveness Analysis
10. Latin America CRISPR Gene-Editing Market Outlook:
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Product
- 10.2.3. By Service
- 10.2.4. By Application
- 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
- 10.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 10.4.1. Kits & Enzymes
- 10.4.2. Libraries
- 10.4.3. Others
- 10.5. Market Size (US$ Bn) Analysis and Forecast, By Service, 2025-2032
- 10.5.1. gRNA Design and Vector Construction
- 10.5.2. Cell Line Engineering
- 10.5.3. Screening Services
- 10.5.4. Other Services
- 10.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 10.6.1. Drug Discovery & Development
- 10.6.2. Agriculture
- 10.6.3. Others
- 10.7. Market Attractiveness Analysis
11. Middle East & Africa CRISPR Gene-Editing Market Outlook:
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Product
- 11.2.3. By Service
- 11.2.4. By Service
- 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
- 11.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 11.4.1. Kits & Enzymes
- 11.4.2. Libraries
- 11.4.3. Others
- 11.5. Market Size (US$ Bn) Analysis and Forecast, By Service, 2025-2032
- 11.5.1. gRNA Design and Vector Construction
- 11.5.2. Cell Line Engineering
- 11.5.3. Screening Services
- 11.5.4. Other Services
- 11.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 11.6.1. Drug Discovery & Development
- 11.6.2. Agriculture
- 11.6.3. Others
- 11.7. Market Attractiveness Analysis
12. Competition Landscape
- 12.1. Market Share Analysis, 2025
- 12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
- 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Revvity, Inc.
- 12.3.1.1. Overview
- 12.3.1.2. Segments and Products
- 12.3.1.3. Key Financials
- 12.3.1.4. Market Developments
- 12.3.1.5. Market Strategy
- 12.3.2. Danaher
- 12.3.3. GenScript
- 12.3.4. Merck KGaA
- 12.3.5. Thermo Fisher Scientific, Inc.
- 12.3.6. Tocris Bioscience
- 12.3.7. OriGene Technologies, Inc.
- 12.3.8. Bio-Rad Laboratories
- 12.3.9. Bio-Techne
- 12.3.10. New England Biolabs, Inc.
- 12.3.1. Revvity, Inc.
13. Appendix
- 13.1. Research Methodology
- 13.2. Research Assumptions
- 13.3. Acronyms and Abbreviations
